end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccruedEmployeeBenefitsCurrent,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AmortizationOfFinancingCosts,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosure,AvailableForSaleSecuritiesCurrent,AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue,AvailableForSaleSecuritiesGrossRealizedGainLossNet,AvailableForSaleSecuritiesNoncurrent,CapitalExpendituresIncurredButNotYetPaid,CapitalizedContractCostNet,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashEquivalentsAtCarryingValue,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract,ContractWithCustomerAssetNet,ContractWithCustomerLiability,ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized,ContractWithCustomerLiabilityCurrent,ContractWithCustomerLiabilityNoncurrent,ContractWithCustomerLiabilityRevenueRecognized,ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod,ConversionOfStockAmountConverted1,ConvertiblePreferredStockSharesIssuedUponConversion,CurrentForeignTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,DebtConversionConvertedInstrumentAmount1,DebtInstrumentCarryingAmount,DebtInstrumentInterestRateEffectivePercentage,DebtInstrumentInterestRateStatedPercentage,DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction,DeferredFinanceCostsNet,DeferredFinanceCostsNoncurrentGross,DeferredForeignIncomeTaxExpenseBenefit,DeferredIncomeTaxAssetsNet,DeferredIncomeTaxExpenseBenefit,DeferredIncomeTaxLiabilities,DeferredOfferingCosts,DeferredRentCreditNoncurrent,DeferredRevenue,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsLiabilitiesNetNoncurrent,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOperatingLossCarryforwardsDomestic,DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal,DeferredTaxAssetsPropertyPlantAndEquipment,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesLeasingArrangements,DefinedContributionPlanAdministrativeExpenses,DefinedContributionPlanCostRecognized,DefinedContributionPlanEmployerDiscretionaryContributionAmount,DefinedContributionPlanEmployerMatchingContributionPercentOfMatch,DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount,Depreciation,DepreciationDepletionAndAmortization,DueFromAffiliateCurrent,DueFromRelatedPartiesCurrent,DueToAffiliateCurrent,DueToRelatedPartiesCurrent,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,FairValueAdjustmentOfWarrants,ForeignCurrencyTransactionLossBeforeTax,ForeignIncomeTaxExpenseBenefitContinuingOperations,GainLossOnSaleOfPropertyPlantEquipment,GainsLossesOnExtinguishmentOfDebt,GeneralAndAdministrativeExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeTaxCreditsAndAdjustments,IncomeTaxExaminationPenaltiesAndInterestExpense,IncomeTaxExpenseBenefit,IncomeTaxesReceivable,IncomeTaxesReceivable,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsPayableRelatedParties,IncreaseDecreaseInAccountsPayableTrade,IncreaseDecreaseInAccountsReceivableRelatedParties,IncreaseDecreaseInContractWithCustomerLiability,IncreaseDecreaseInDeferredRevenue,IncreaseDecreaseInIncomeTaxesReceivable,IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInOtherOperatingLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncreaseInCarryingAmountOfRedeemablePreferredStock,InterestExpense,InterestPaidNet,InterestPayableCurrent,InvestmentIncomeInterest,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesFairValueDisclosure,LongTermDebt,LongTermDebtFairValue,MarketableSecuritiesCurrent,MarketableSecuritiesNoncurrent,MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFiveYears,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsDueThereafter,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OperatingLeasesRentExpenseNet,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccountsPayableAndAccruedLiabilities,OtherAccruedLiabilitiesCurrent,OtherAssetsCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax,OtherComprehensiveIncomeLossNetOfTax,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherLiabilitiesNoncurrent,OtherNonoperatingIncomeExpense,OtherPrepaidExpenseCurrent,OtherReceivablesNetCurrent,PaymentsForProceedsFromTenantAllowance,PaymentsOfDebtIssuanceCosts,PaymentsOfStockIssuanceCosts,PaymentsToAcquireAvailableForSaleSecurities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,ProceedsFromDebtNetOfIssuanceCosts,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfDebt,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,ProceedsFromSaleOfPropertyPlantAndEquipment,ProceedsFromStockOptionsExercised,ProceedsFromStockPlans,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ReceivablesLongTermContractsOrPrograms,RepaymentsOfLongTermDebt,ResearchAndDevelopmentExpense,RestrictedCashAndCashEquivalentsAtCarryingValue,RestrictedCashCurrent,RestrictedCashNoncurrent,RestructuringCharges,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerIncludingAssessedTax,RevenueFromRelatedParties,RevenueRemainingPerformanceObligation,Revenues,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SecurityDeposit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueShareBasedCompensation,StockIssuedDuringPeriodValueStockOptionsExercised,StockRepurchasedAndRetiredDuringPeriodValue,SubleaseIncome,TangibleAssetImpairmentCharges,TemporaryEquityAccretionToRedemptionValue,TemporaryEquityAccretionToRedemptionValueAdjustment,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityLiquidationPreference,TemporaryEquityParOrStatedValuePerShare,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate,ValuationAllowanceDeferredTaxAssetChangeInAmount,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,OperatingLeaseExpense,OperatingLeaseRightOfUseAssetAmortizationExpense,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2016-06-30,2016-09-15,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,1441000.0,,695000.0,2669000.0,735000.0,,-101000.0,158000.0,,106000.0,,9887412.0,24516000.0,22417000.0,19043000.0,6408000.0,,,,,,13768000.0,,13778000.0,,12635000.0,9996446.0,0.0,160000000.0,383910.0,383910.0,0.0,-7103000.0,,,,,,,,,,,,,,,,,,,,,,,,1466000.0,,,,,,,,,,,,,,,,,,,,,,,,,,-19.07,,,,,,,,,,1600000.0,0.0,,,,,1395000.0,,,,,,,,,,,,,,,,,,,,,,,,27000.0,,,,,,,,,,,4110000.0,24516000.0,4110000.0,,,,,,,,,,,,,-7098000.0,-7323000.0,,,7091000.0,-7091000.0,,,,,,,,,,,,,,,,,2669000.0,259000.0,,34000.0,,,-1000.0,-4000.0,,,,,-34000.0,,,,,,,,,,,,,,487000.0,,,,,,,,,,,,,,,599000.0,,,5696000.0,10000.0,10000.0,0.0,,-46261000.0,,,,,,,,,,,,,,,,0.0,0.625,,,0.0138,,,,,,,,,,,,,,,,,,-46204000.0,,,,,,,,,,,225000.0,225000.0,66610000.0,65038000.0,0.0,126374911.0,124374909.0,124374909.0,,,,,,,,,383910.0,,,
2016-09-30,2016-11-14,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2335000.0,,1074000.0,3014000.0,,,-24000.0,150863000.0,,448000.0,,1496156.0,102843000.0,102245000.0,97621000.0,2499000.0,,,,,,96024000.0,,96034000.0,,95122000.0,2565984.0,0.0,90000000.0,16714453.0,16714453.0,0.0,-7008000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.87,,,,,,,,,,2800000.0,0.0,,,,,1577000.0,,,,,,,,,,,,,,,,,,,,,,,,54000.0,,,,,,,,,,,5349000.0,102843000.0,5349000.0,,,,,,,,,,,,,-7084000.0,-7377000.0,,,7138000.0,-7138000.0,,,,,,,,,,,,,,,,,3014000.0,310000.0,,34000.0,,,1000.0,75000.0,,,,,0.0,,,,,,,,,0.0,10000000.0,0.0,0.0,,1768000.0,,,,,,,,,,,,,,,564000.0,,,5561000.0,10000.0,10000.0,0.0,,-53345000.0,,,,0.0,,,,,,,,,,,,0.0,0.628,,,0.0138,,,,,,,6.09,,,,,,,,,,,97494000.0,,,,,,,,,,,293000.0,293000.0,,,0.0,0.0,0.0,0.0,,,,,,,,,8483189.0,,,
2016-12-31,2017-03-07,10-K,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,1163000.0,-117000.0,1420000.0,5272000.0,115000.0,1313000.0,-245000.0,152393000.0,2130000.0,2130000.0,,2393829.0,93990000.0,83244000.0,85169000.0,56515000.0,56515000.0,0.0,10150000.0,21000.0,,21084000.0,17029000.0,21094000.0,17029000.0,18504000.0,2558157.0,0.0,90000000.0,16722280.0,16722280.0,0.0,-37320000.0,,0.0,0.0,,,,,,66904000.0,,,,,,,,,,,,,,,,0.0,0.0,23971000.0,0.0,,,21501000.0,1100000.0,600000.0,419000.0,1143000.0,908000.0,23971000.0,,,,,,,317000.0,317000.0,,,,,-6.47,0.0,0.34,-0.36,,-0.016,-0.004,0.065,22000.0,22000.0,12600000.0,525000.0,,,-34000.0,,6961000.0,-34977000.0,-37177000.0,-2200000.0,,,0.0,,2241000.0,-115000.0,,,,,,1588000.0,3395000.0,4000.0,,1804000.0,558000.0,,,,242000.0,,,,,,,,,,,6435000.0,93990000.0,6435000.0,,,,,,,106307000.0,106307000.0,-59328000.0,-59328000.0,-29972000.0,-29972000.0,-48425000.0,-37735000.0,,,32666000.0,-44063000.0,,,,,,,455000.0,368000.0,,,,87000.0,,,408000.0,,5272000.0,120000.0,498000.0,34000.0,-67000.0,-76000.0,-67000.0,-76000.0,-143000.0,-143000.0,,,-34000.0,,,,,,73169000.0,,347000.0,0.0,10000000.0,0.0,0.0,0.0,3394000.0,408000.0,,83648000.0,,,,22508000.0,151000.0,14188000.0,32000.0,151000.0,,-37177000.0,1875000.0,562000.0,0.0,,25705000.0,10000.0,10000.0,0.0,,-64593000.0,,,,,,30000.0,2130000.0,,,,,,,,,0.0,0.5248,0.648,0.625,,0.0179,0.0127,,,169000.0,,8.2,,,,,,,,,,,87555000.0,,,,66904000.0,83648000.0,,151000.0,,,0.0,558000.0,558000.0,36996000.0,41538000.0,0.0,126374911.0,0.0,0.0,2131000.0,,,0.0,619000.0,707000.0,,13400000.0,6501796.0,,,
2017-03-31,2017-05-10,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,1132000.0,-122000.0,847000.0,6647000.0,732000.0,,-22000.0,153610000.0,,843000.0,,2306482.0,82673000.0,67548000.0,75322000.0,53731000.0,,0.0,14000000.0,118000.0,,9517000.0,,9977000.0,-11117000.0,7591000.0,,0.0,90000000.0,16834647.0,16834647.0,0.0,-13878000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88000.0,,,,,-0.84,,,,,,,,,115000.0,11300000.0,0.0,,,,,2991000.0,,,,,,,,,-151000.0,,,,,,102000.0,1359000.0,,,-1586000.0,,,,,172000.0,,,,,,,,,,,,82673000.0,7779000.0,,,,,,,374000.0,374000.0,-1250000.0,-1250000.0,-10356000.0,-10356000.0,-14101000.0,-14101000.0,,,14273000.0,-14273000.0,,,,,,,13817000.0,,2054000.0,1995000.0,1936000.0,1706000.0,5401000.0,725000.0,,,6647000.0,108000.0,,34000.0,-14000.0,237000.0,-14000.0,237000.0,,,,,,,,,,,8002000.0,,48000.0,0.0,10000000.0,0.0,0.0,0.0,1810000.0,,,,,,,0.0,374000.0,6800000.0,,,374000.0,-14101000.0,,641000.0,,,11282000.0,,10000.0,450000.0,,-78694000.0,,,,,,450000.0,843000.0,,,,,,,,,0.0,0.625,,,0.0207,,,,,,,7.57,,,,,,,,,,,74894000.0,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,16766218.0,,,
2017-06-30,2017-08-08,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2639000.0,,1338000.0,6727000.0,669000.0,,3000.0,154700000.0,,1001000.0,,2476521.0,70479000.0,69126000.0,63363000.0,54127000.0,,,0.0,,,10365000.0,,10825000.0,,9236000.0,,0.0,90000000.0,16899261.0,16899261.0,0.0,-14954000.0,,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,83000.0,,,,,,,,,,,,,,,,,,,,,,,,,-0.89,,,,,,,,,,11600000.0,0.0,,,,,3124000.0,,,,,,,,,,,,,,,,,,,,,,,,152000.0,,,,,,,,,,,9449000.0,70479000.0,9366000.0,,,,,,,,,,,,,-14979000.0,-14979000.0,,,15131000.0,-15131000.0,,,,,,,13389000.0,,2059000.0,1999000.0,1941000.0,1667000.0,5228000.0,495000.0,,,6727000.0,171000.0,,0.0,11000.0,14000.0,11000.0,14000.0,,,,,0.0,,,,,,,,,0.0,10000000.0,0.0,0.0,0.0,1743000.0,,,,,,,,,,,,,,,903000.0,,,12007000.0,,10000.0,450000.0,,-93673000.0,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,61030000.0,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,16875627.0,,,
2017-09-30,2017-11-07,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2267000.0,,1611000.0,8241000.0,709000.0,,100000.0,156234000.0,,1207000.0,,2564354.0,110415000.0,97704000.0,102146000.0,43191000.0,,,11316000.0,,0.0,50395000.0,,50855000.0,,47638000.0,,0.0,90000000.0,16944103.0,16944103.0,0.0,-4728000.0,,520000.0,41739000.0,,,,0.0,0.0,,,,,,,,,,,,,,,,,332000.0,41739000.0,,,,,,,,,,,,,,,,,,,,,,,,-0.29,,,,,,,,,,11700000.0,0.0,,,,,2593000.0,,,,,,,,,,,,,,,,,,,,,,,,155000.0,,,,,,,,,,,52579000.0,110415000.0,52247000.0,,,,,,,,,,,,,-4825000.0,-4825000.0,,,13761000.0,-4980000.0,,,,,,,13159000.0,,2059000.0,2000000.0,1941000.0,1667000.0,5228000.0,264000.0,,,8241000.0,57000.0,,0.0,24000.0,73000.0,24000.0,73000.0,,,,,0.0,,,,,,,,,0.0,10000000.0,0.0,0.0,0.0,2703000.0,,,,,,,,,,,,,,,945000.0,520000.0,,11168000.0,,10000.0,450000.0,,-98498000.0,8781000.0,8781000.0,,8781000.0,,,,,,,,,,,,0.0,0.621,,,0.02,,,,,,,,,,,,,,,,,,57836000.0,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,16911575.0,,,
2017-12-31,2018-03-07,10-K,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,1257000.0,-687000.0,2718000.0,9546000.0,267000.0,1594000.0,-6000.0,222188000.0,4241000.0,4241000.0,,2463089.0,163734000.0,150947000.0,153778000.0,37972000.0,37972000.0,,11458000.0,,0.0,106029000.0,,106489000.0,85395000.0,104348000.0,,0.0,90000000.0,21088306.0,21088306.0,0.0,-36718000.0,,1816000.0,,,31752000.0,,0.0,,,,,,,,,,,,,,,,,,547000.0,31752000.0,25887000.0,,,,21682000.0,,,339000.0,2544000.0,,25887000.0,,,,,,,406000.0,406000.0,1816000.0,1816000.0,,,-2.2399999999999998,,0.34,-0.052,-0.312,-0.012,0.005,0.005,,146000.0,10700000.0,0.0,,,62000.0,,11779000.0,-34556000.0,-36957000.0,-2401000.0,,,0.0,1700000.0,1347000.0,91000.0,,91000.0,1816000.0,31752000.0,31752000.0,-1070000.0,4793000.0,,,333000.0,,,,,948000.0,,,,,,,,,,,43102000.0,163734000.0,42555000.0,,,,,,,65554000.0,,15823000.0,,3872000.0,,-40009000.0,-36957000.0,185000.0,,57960000.0,-41410000.0,,,,,,,12895000.0,1667000.0,2121000.0,2060000.0,2000000.0,1941000.0,3106000.0,,1400000.0,,9546000.0,124000.0,1071000.0,,-59000.0,298000.0,,,,239000.0,-59000.0,,-8000.0,936000.0,135000.0,,,,39546000.0,39546000.0,666000.0,0.0,10000000.0,0.0,0.0,,3773000.0,378000.0,,,,,,,1007000.0,56035000.0,,,,-36957000.0,2473000.0,879000.0,,,46181000.0,,10000.0,450000.0,,-101550000.0,31345000.0,31345000.0,53900000.0,,,,4241000.0,,,,,,,,,,,,,,,,,,3500000.0,,7.74,,2438151.0,11.51,,,,,,,,120632000.0,,,,,64547000.0,1007000.0,,,0.0,0.0,0.0,,,,,,,0.0,5414000.0,,0.0,0.0,3283000.0,,,1900000.0,17694505.0,,,
2018-03-31,2018-05-09,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,1307000.0,-120000.0,1267000.0,10358000.0,486000.0,,-72000.0,223904000.0,1185000.0,1185000.0,,3122462.0,149239000.0,142231000.0,139028000.0,65383000.0,,,5557000.0,36000.0,0.0,69577000.0,,70037000.0,-36452000.0,68088000.0,,0.0,90000000.0,21163590.0,21163590.0,,-7727000.0,,2722000.0,,,21880000.0,,10500000.0,0.0,,,,,,,,,,,,,,,,,694000.0,,,,,,,,,,,,,,,,,,,,78000.0,2722000.0,,379000.0,,-0.36,,0.35,,,,,,,,15700000.0,,,,,,3642000.0,,-7661000.0,,,,0.0,2500000.0,1918000.0,21000.0,379000.0,,906000.0,-9872000.0,,606000.0,974000.0,,,-1150000.0,,,,,568000.0,,,,,,,,,,,34618000.0,149239000.0,33924000.0,,,,,,,530000.0,,-21844000.0,,-15138000.0,,-7661000.0,,,,19010000.0,-8229000.0,,,,,,,12562000.0,,2121000.0,2060000.0,2000000.0,1941000.0,3106000.0,1334000.0,,,10358000.0,328000.0,,,-48000.0,-18000.0,,,,-66000.0,,,,,,,,,25636000.0,,208000.0,0.0,10000000.0,0.0,0.0,,2621000.0,,,,,,,,530000.0,4000000.0,,,,-7661000.0,,1001000.0,,,15368000.0,,10000.0,450000.0,,-109211000.0,10781000.0,,,,,,1185000.0,,,113625.0,16.95,113625.0,16.95,,,,,,,,,,952059.0,9.92,,629950.0,10.51,5900000.0,2984522.0,12.67,5900000.0,2984522.0,12.67,4.4,20.12,16.91,3300000.0,114621000.0,,33072.0,50507.0,,,531000.0,,,,,,,,,,,,,,,,,,,,,21112393.0,,,
2018-06-30,2018-08-07,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2278000.0,,2080000.0,13262000.0,441000.0,,-86000.0,225622000.0,1645000.0,1645000.0,,3204660.0,137473000.0,136111000.0,122721000.0,61303000.0,,,,,0.0,63864000.0,,64324000.0,,61418000.0,,0.0,90000000.0,21217494.0,21217494.0,,-8677000.0,,5785000.0,,,13202000.0,,11500000.0,,,,,,,,,,,,,,,,,,793000.0,,,,,,,,,,,,,,,,,,,,,5785000.0,,276000.0,,-0.41,,,,,,,,,,14800000.0,,,,,,3178000.0,,-8663000.0,,,,0.0,3000000.0,2190000.0,,,,,,,,,,,,,,,,576000.0,,,,,,,,,,,29811000.0,137473000.0,29018000.0,,,,,,,,,,,,,-8663000.0,,,,20913000.0,-9239000.0,,,,,,,12182000.0,,2121000.0,2060000.0,2000000.0,1941000.0,3106000.0,954000.0,,,13262000.0,166000.0,,,54000.0,-68000.0,,,,-14000.0,,,,,,,,,,,,0.0,10000000.0,0.0,0.0,,2959000.0,,,,,,,,,,,,,,,912000.0,,,17735000.0,,10000.0,450000.0,,-117874000.0,11674000.0,,,,,,,,,,,113625.0,16.95,,,0.0,,,,,,,1150254.0,10.56,,,,3700000.0,3071618.0,12.54,3700000.0,3071618.0,12.54,,,,2300000.0,107662000.0,,,,,,73000.0,,,,,,,,,,,,,,,,,,,,,21207234.0,,,
2018-09-30,2018-11-06,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,4871000.0,,2410000.0,10496000.0,332000.0,,-103000.0,250670000.0,2017000.0,2017000.0,,6376811.0,148856000.0,147502000.0,135180000.0,51090000.0,,,,,0.0,87427000.0,,87887000.0,,84090000.0,,0.0,90000000.0,24138102.0,24138102.0,,-8752000.0,,,,,7970000.0,,5900000.0,0.0,,,,,,,,,,,,,,,,,797000.0,,,,,,,,,,,,,,,,,,,,,,4586000.0,,764000.0,-0.38,,,,,,,,,,17600000.0,,,,,,3361000.0,,-8735000.0,,,,0.0,1600000.0,1155000.0,,,,,,,,,,,,,,,,654000.0,,,,,,,,,,,24898000.0,148856000.0,24101000.0,,,,,,,,,,,,,-8735000.0,,,,15506000.0,-9389000.0,,,,,,,11705000.0,,2121000.0,2060000.0,2000000.0,1941000.0,3106000.0,477000.0,,,10496000.0,105000.0,,,46000.0,-63000.0,,,,-17000.0,,,,,,,,,,,,0.0,10000000.0,0.0,0.0,,3234000.0,,,,,,,,,,,,,,,904000.0,,,12145000.0,,10000.0,450000.0,,-126609000.0,6117000.0,,,,,,,,,,,420650.0,10.45,,,0.0,,,,,,,1311184.0,11.05,,,,7800000.0,3153479.0,12.37,7800000.0,3153479.0,12.37,,,,4600000.0,123958000.0,,,,,1025000.0,327000.0,,,,,,,,,,,,,,,,,,,,,22912279.0,,,
2018-12-31,2019-03-12,10-K,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,5711000.0,-206000.0,2726000.0,11163000.0,61000.0,2077000.0,-233000.0,253222000.0,6919000.0,6919000.0,,6399025.0,139472000.0,137503000.0,,46620000.0,46620000.0,,,24000.0,0.0,82233000.0,,82693000.0,-23796000.0,80883000.0,,0.0,90000000.0,23187219.0,23187219.0,0.0,-39151000.0,,,,,8223000.0,,23500000.0,,,,,,,,,,,,,-799000.0,658000.0,-799000.0,,,799000.0,,34698000.0,,658000.0,658000.0,27704000.0,,,269000.0,4270000.0,,34040000.0,,,,,,,527000.0,527000.0,,4587000.0,,1061000.0,-2.31,0.02,0.21,-0.222,,0.004,-0.029,0.07,,-177000.0,15600000.0,0.0,,,,,13697000.0,-37511000.0,-39723000.0,-2212000.0,-658000.0,,-799000.0,,1429000.0,4430000.0,1061000.0,4430000.0,2771000.0,-23529000.0,,236000.0,1911000.0,,,-1117000.0,,,,,2566000.0,,,,,,,,,,,26957000.0,139472000.0,26158000.0,,,,46620000.0,,,24115000.0,,2213000.0,,-49947000.0,,-52789000.0,-38924000.0,,,73194000.0,-57681000.0,,,,,,,11228000.0,1941000.0,2185000.0,2121000.0,2059000.0,2000000.0,922000.0,,1900000.0,,11163000.0,595000.0,,,95000.0,-322000.0,,,,-227000.0,95000.0,,-20000.0,1005000.0,495000.0,,,,71060000.0,71060000.0,486000.0,0.0,10000000.0,0.0,0.0,,2624000.0,438000.0,1508000.0,,1508000.0,,,,934000.0,73759000.0,,,,-38924000.0,2938000.0,861000.0,,,59497000.0,,10000.0,450000.0,,-140474000.0,33278000.0,,60700000.0,,,,6919000.0,,,,,418450.0,10.45,,,,,,,,,,,,1300000.0,42950.0,8.12,,3178441.0,12.23,,,,,,,,112515000.0,,,,,,934000.0,,6670000.0,0.0,0.0,0.0,,,,,,,0.0,9466000.0,,0.0,0.0,3944000.0,108000.0,2700000.0,8200000.0,22364515.0,,,
2019-03-31,2019-05-08,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,6454000.0,94000.0,1703000.0,8713000.0,425000.0,2209000.0,-189000.0,255591000.0,1979000.0,1979000.0,,6986783.0,132248000.0,122995000.0,,42469000.0,,,,649000.0,0.0,70077000.0,,70537000.0,-12156000.0,61509000.0,,0.0,90000000.0,23392534.0,23392534.0,,-14059000.0,,,,,7001000.0,,1200000.0,,,,,,,,,,,,,,,,,,,,,,478000.0,,,,,,,,,,,,,,,,130000.0,,5061000.0,,1211000.0,-0.58,-0.013,0.21,,,,,,,8000.0,15400000.0,,,,,,3764000.0,,-13920000.0,,180000.0,,183000.0,,1876000.0,696000.0,150000.0,696000.0,474000.0,-1222000.0,,441000.0,-3053000.0,,,406000.0,,,,,731000.0,,10439000.0,895000.0,,2121000.0,2059000.0,2000000.0,1942000.0,1422000.0,2395000.0,31423000.0,132248000.0,24499000.0,,,,,,,390000.0,,4108000.0,,-16662000.0,,-14103000.0,,,1.0,16208000.0,-14648000.0,459000.0,8044000.0,1120000.0,6924000.0,463000.0,6779000.0,,,,,,,,,,0.11,8713000.0,96000.0,,,29000.0,15000.0,,,,44000.0,29000.0,,-3000.0,,,,,,21726000.0,21726000.0,166000.0,0.0,10000000.0,0.0,0.0,,3502000.0,,,,,,,,390000.0,26000000.0,,,,-14103000.0,3755000.0,1546000.0,,,12444000.0,,10000.0,450000.0,,-154577000.0,1560000.0,,,,,450000.0,1979000.0,-36175.0,9.86,160650.0,8.02,423572.0,9.69,119353.0,10.04,,,,,,,,1670483.0,11.53,,788300.0,4.7,14100000.0,3772561.0,11.45,14100000.0,3772561.0,11.45,1.55,12.48,7.97,7200000.0,100825000.0,,151941.0,42239.0,,,390000.0,,,,,,,,,,,,,,,,,,,,,24297576.0,,,
2019-06-30,2019-08-07,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2787000.0,,2460000.0,10845000.0,529000.0,2383000.0,-167000.0,268234000.0,2013000.0,2013000.0,,,148105000.0,137320000.0,,,,,,,1600000.0,71143000.0,,71603000.0,,66210000.0,,0.0,90000000.0,24967603.0,24967603.0,,-29152000.0,-8189000.0,,,,17717000.0,23850000.0,1600000.0,,,,,,,,,,,,,,2104000.0,,,,,,,,,,,,,,,,,,,,,,,,,,4889000.0,,810000.0,-1.18,-0.053,0.21,,,,,,,,16200000.0,,,-1100000.0,,,3863000.0,,-30803000.0,,,,-1629000.0,,1421000.0,,,,,,,,,,,,,,,,641000.0,,9970000.0,895000.0,,2121000.0,2059000.0,2000000.0,1941000.0,954000.0,2190000.0,63789000.0,148105000.0,33323000.0,,,,54958000.0,,,,,,,,,-29174000.0,,,,23218000.0,-31407000.0,444000.0,7780000.0,1164000.0,6616000.0,,6539000.0,,,,,,,,,,0.11,10845000.0,22000.0,,,41000.0,-19000.0,,,,22000.0,41000.0,,-37000.0,,,,,,,,,0.0,10000000.0,0.0,0.0,,4899000.0,,,,,,,,,,,,,,4075000.0,1692000.0,,,19355000.0,,10000.0,450000.0,,-183751000.0,,,,,,,,,,,,368571.0,9.68,,,0.0,,,,,,,1802359.0,11.57,,,,12300000.0,3780445.0,11.51,12300000.0,3780445.0,11.51,,,,7400000.0,84316000.0,,,,,10543000.0,87000.0,,,21000.0,,,,,,,,,,,,,,,,,,24662779.0,,,
2019-09-30,2019-11-06,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,1583000.0,,3480000.0,10486000.0,376000.0,2559000.0,-154000.0,295672000.0,2201000.0,2201000.0,,,154627000.0,144023000.0,,,,,,,0.0,50195000.0,,50655000.0,,44450000.0,,0.0,90000000.0,27206447.0,27206447.0,,-16396000.0,,,,,16478000.0,22200000.0,2900000.0,,,,,,,,,,,,,,2125000.0,,,,,,,,,,,,,,,,,,,,,,,,,,1945000.0,,1020000.0,-0.61,-0.006,0.21,,,,,,,,14200000.0,,,,,,4015000.0,,-16511000.0,,,,-102000.0,,173000.0,,,,,,,,,,,,,,,,762000.0,,9493000.0,895000.0,,2121000.0,2059000.0,2000000.0,1941000.0,477000.0,1991000.0,59269000.0,154627000.0,30776000.0,,,,87497000.0,,,,,,,,,-16409000.0,,,,21308000.0,-17167000.0,444000.0,7502000.0,1209000.0,6293000.0,,6295000.0,,,,,,,,,,0.11,10486000.0,210000.0,,,3000.0,10000.0,,,,13000.0,3000.0,,-106000.0,,,,,,,,,0.0,10000000.0,0.0,0.0,,4203000.0,,,,,,,,,,,,,,4293000.0,1734000.0,,,17293000.0,,10000.0,450000.0,,-200160000.0,4141000.0,,,,,,,,,,,284445.0,10.09,,,0.0,,,,,,,1870596.0,11.98,,,,10700000.0,3709631.0,11.77,10700000.0,3709631.0,11.77,,,,6600000.0,95358000.0,,,,,23949000.0,1288000.0,,,21000.0,,,,,,,,,,,,,,,,,,26956957.0,,,
2019-12-31,2020-03-10,10-K,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2790000.0,594000.0,4637000.0,12360000.0,301000.0,2641000.0,-221000.0,297846000.0,8353000.0,8353000.0,13000.0,6750278.0,154917000.0,145311000.0,,,100011000.0,,,100000.0,0.0,33006000.0,,33466000.0,-49227000.0,31707000.0,,0.0,90000000.0,27217649.0,27217649.0,,-77175000.0,,,,,17738000.0,23792000.0,1600000.0,,,,84000.0,84000.0,,10000000.0,0.0981,0.0785,,222000.0,235000.0,-775000.0,1433000.0,-775000.0,1269000.0,,,,55233000.0,,,1433000.0,39907000.0,,,318000.0,8038000.0,,52531000.0,1269000.0,,,0.0,,,703000.0,732000.0,,6755000.0,,1262000.0,-3.61,0.009,0.21,-0.238,,0.007,-0.025,0.012,,-26000.0,12300000.0,,,,-8000.0,,15749000.0,-72271000.0,-77878000.0,-5607000.0,-775000.0,,-691000.0,,,,201000.0,-3000000.0,2168000.0,33307000.0,,-1411000.0,1098000.0,,,2820000.0,,169000.0,70000.0,68000.0,2813000.0,1728000.0,9016000.0,,1941000.0,895000.0,2121000.0,2059000.0,2000000.0,,1799000.0,74953000.0,154917000.0,35406000.0,,9794000.0,,100011000.0,,0.0,46036000.0,,-53710000.0,,-41527000.0,,-94688000.0,,,,80752000.0,-97820000.0,1792000.0,7217000.0,1256000.0,5961000.0,1885000.0,6042000.0,,,,,,,,,,0.11,12360000.0,122000.0,,,,-44000.0,,,,12000.0,56000.0,,-1000.0,1057000.0,744000.0,469000.0,,,,166936000.0,967000.0,0.0,10000000.0,0.0,0.0,,5529000.0,1161000.0,34492000.0,,34492000.0,9765000.0,9765000.0,,1779000.0,114193000.0,,,,-77187000.0,4322000.0,1681000.0,,,65003000.0,,10000.0,450000.0,,-217661000.0,2950000.0,,112900000.0,,,,8353000.0,102915.0,9.88,160650.0,8.02,278482.0,10.08,197703.0,9.29,,,,,,,,1973866.0,11.82,2600000.0,1328800.0,5.45,2400000.0,3681521.0,11.64,2400000.0,3681521.0,11.64,3.81,14.08,9.36,2300000.0,79964000.0,,518665.0,307055.0,,,1779000.0,,,64000.0,0.0,,,,,,,,0.0,16631000.0,,0.0,0.0,6981000.0,184000.0,4100000.0,18500000.0,25894024.0,,1792000.0,7300000.0
2020-03-31,2020-05-07,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,3704000.0,164000.0,1731000.0,11616000.0,725000.0,,107000.0,300300000.0,2048000.0,2048000.0,21000.0,7651141.0,134901000.0,125986000.0,,,,,,5000.0,0.0,60215000.0,,60675000.0,27209000.0,58728000.0,,0.0,90000000.0,27434705.0,27434705.0,,-19752000.0,,,,,18630000.0,20415000.0,1200000.0,,,,,,,10000000.0,0.0977,0.0785,,208000.0,,,1082000.0,,,,,,,,,,,,,,,,,,,0.0,,,,,217000.0,,3594000.0,,1116000.0,-0.72,-0.009,0.21,,,,,,,-72000.0,16200000.0,,549000.0,,,,4576000.0,,-19904000.0,,183000.0,,176000.0,,153000.0,,-146000.0,913000.0,-3161000.0,-2485000.0,,162000.0,-700000.0,,,-806000.0,,243000.0,,68000.0,526000.0,,,,,,,,,,,72235000.0,134901000.0,36372000.0,,9832000.0,,57298000.0,,,399000.0,,42730000.0,,-15848000.0,,-20080000.0,,,1.0,23344000.0,-19697000.0,,,1306000.0,5616000.0,477000.0,5780000.0,,,,,,,,,,,11616000.0,136000.0,,,,338000.0,,,,328000.0,-10000.0,,-490000.0,,,,7000.0,,,20883000.0,138000.0,0.0,10000000.0,0.0,0.0,,4716000.0,,,,,,,,406000.0,63751000.0,,,,-20080000.0,,1603000.0,,,18768000.0,,10000.0,450000.0,,-237741000.0,,,113600000.0,,,,2048000.0,9338.0,9.35,142000.0,7.8,279997.0,9.21,131147.0,9.52,,,0.738,0.721,,0.0144,0.0059,2167161.0,11.9,,977600.0,5.01,2200000.0,4577587.0,10.87,2200000.0,4577587.0,10.87,1.5,11.85,7.78,2200000.0,62666000.0,,52367.0,29167.0,,,406000.0,,,,,,,,,,,,,,,,,,,,,27703918.0,,,
2020-06-30,2020-08-06,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2855000.0,,2808000.0,12917000.0,649000.0,,-208000.0,424855000.0,1996000.0,1996000.0,,,224980000.0,217466000.0,,,,,,,,146242000.0,,146702000.0,,141027000.0,,0.0,90000000.0,36802139.0,36802139.0,,-19736000.0,,,,2100000.0,17230000.0,16784000.0,2100000.0,,,,,,,,,0.0785,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2997000.0,,1003000.0,-0.59,0.062,0.21,,,,,,,,14700000.0,,,,,-585000.0,4177000.0,,-18292000.0,,,,1129000.0,,276000.0,,,,,,,,,,,,,209000.0,,,207000.0,,,,,,,,,,,57495000.0,224980000.0,35360000.0,,,,62423000.0,,,,,,,,,-19421000.0,,,,24434000.0,-18217000.0,,,1355000.0,5259000.0,,5511000.0,,,,,,,,,,,12917000.0,36000.0,,,,-324000.0,,,,-315000.0,9000.0,92000.0,512000.0,,,,,,,,,0.0,10000000.0,0.0,0.0,,5518000.0,,,,,,,,,,,,,,,1553000.0,,,20257000.0,,10000.0,450000.0,300000.0,-257162000.0,,,113900000.0,,,,,,,,,262608.0,9.24,,,,,0.745,0.743,,0.0042,0.0039,2383602.0,12.02,,,,32800000.0,4537986.0,11.04,32800000.0,4537986.0,11.04,,,,16000000.0,167485000.0,,,,,105331000.0,585000.0,,,,,,,,,,,,,,,,,,,,,32799691.0,,,
2020-09-30,2020-11-04,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2797000.0,,4371000.0,15518000.0,857000.0,,-88000.0,434603000.0,1888000.0,1888000.0,,,217320000.0,204151000.0,,,,,,,,83625000.0,,84085000.0,,79285000.0,,0.0,90000000.0,37314873.0,37314873.0,,-7643000.0,,,,8500000.0,16765000.0,4112000.0,8500000.0,,,,,,,,,0.0785,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,2789000.0,,2077000.0,-0.21,,0.21,,,,,,,,14700000.0,,,,,,4891000.0,,-7763000.0,,,,0.0,,535000.0,,,,,,,,,,,,,19000.0,,2000.0,87000.0,,,,,,,,,,,47730000.0,217320000.0,38563000.0,,,,110349000.0,6025000.0,,,,,,,,-7763000.0,,,,20886000.0,-7772000.0,,,1406000.0,4885000.0,,5235000.0,,,,,,,,,,,15518000.0,128000.0,,,,129000.0,,,,120000.0,-9000.0,170000.0,-59000.0,,,,,,,,,0.0,10000000.0,0.0,0.0,,6843000.0,,,,,,,,,,,,,,,1459000.0,,,15995000.0,,10000.0,450000.0,300000.0,-264925000.0,13114000.0,,,,,,,,,,,,,,,,,,,,,,2464699.0,12.15,,,,38800000.0,4596819.0,11.47,38800000.0,4596819.0,11.47,,,,19600000.0,169590000.0,,,,,-3000.0,1495000.0,,,,,,,,,,,,,,,,,,,,,37386881.0,,,
2020-12-31,2021-03-10,10-K,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,3075000.0,-37000.0,6413000.0,18498000.0,668000.0,3473000.0,28000.0,563389000.0,7899000.0,7899000.0,,7671110.0,324468000.0,315606000.0,,,,,,85000.0,0.0,117358000.0,,117818000.0,84352000.0,113693000.0,,1e-05,90000000.0,43745465.0,43745465.0,,-65901000.0,,,,,14477000.0,,14100000.0,,,,-88000.0,-88000.0,,,0.0985,0.0785,205000.0,,,1393000.0,,1393000.0,1040000.0,,,,72949000.0,,,,50272000.0,,,1237000.0,14856000.0,,71909000.0,1040000.0,,,0.0,,,789000.0,948000.0,,2426000.0,,2732000.0,-1.92,-0.02,0.21,-0.343,,-0.009,0.038,0.019,,175000.0,16000000.0,,,,,-585000.0,18638000.0,-71073000.0,-64845000.0,6228000.0,1438000.0,0.0,1305000.0,,1084000.0,,1471000.0,309000.0,-4329000.0,-27053000.0,,990000.0,5840000.0,,121000.0,1102000.0,,598000.0,438000.0,,900000.0,1686000.0,7075000.0,,2000000.0,,895000.0,2121000.0,2059000.0,,1116000.0,44862000.0,324468000.0,40241000.0,,,0.0,188451000.0,2000000.0,0.0,247626000.0,,-90965000.0,,-72484000.0,,-66150000.0,,,,93144000.0,-64516000.0,1775000.0,5959000.0,1459000.0,4500000.0,1941000.0,4950000.0,,,,,,,,,,0.11,18498000.0,82000.0,,,,266000.0,,,,249000.0,-17000.0,121000.0,-46000.0,1009000.0,311000.0,,14000.0,,,280027000.0,471000.0,1e-05,10000000.0,0.0,0.0,,6277000.0,1440000.0,42062000.0,,213303000.0,,,,2799000.0,189533000.0,,,,-66150000.0,4935000.0,1462000.0,,10524000.0,74506000.0,,10000.0,450000.0,,-283811000.0,28628000.0,,98600000.0,,,,7899000.0,,,,,,,,,,,,,,,,2619943.0,12.1,3000000.0,1536400.0,7.76,40000000.0,4648120.0,11.87,40000000.0,4648120.0,11.87,7.49,11.54,11.53,22100000.0,279606000.0,,275563.0,294238.0,,212974000.0,2799000.0,,,89000.0,0.0,,,,,,,,0.0,19885000.0,3799000.0,0.0,,7053000.0,,,19400000.0,34396446.0,,1775000.0,7100000.0
2021-03-31,2021-05-04,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,2732000.0,-348000.0,1775000.0,17680000.0,723000.0,,-33000.0,567176000.0,2660000.0,2660000.0,,9023822.0,298072000.0,285508000.0,,,,,,97000.0,,83000000.0,,83225000.0,-34593000.0,79151000.0,,1e-05,90000000.0,43939246.0,43939246.0,,-24059000.0,,,,,5768000.0,,1100000.0,,,,,,,,,,58000.0,,,,,,,,,,,,,,,,,,,,,,200000.0,,,0.5,3500.0,,180000.0,,3996000.0,,6823000.0,-0.54,-0.009,0.21,,,,,,,-23000.0,42700000.0,,,,,,5965000.0,,-23998000.0,,,,0.0,,1823000.0,,4091000.0,-344000.0,1570000.0,-8709000.0,,751000.0,-673000.0,,,-57000.0,,,,,102000.0,,,,,,,,,,,38738000.0,298072000.0,34515000.0,,,,190476000.0,6254000.0,,979000.0,,-6793000.0,,-28756000.0,,-23998000.0,,,1.0,30210000.0,-24021000.0,,,1512000.0,4102000.0,491000.0,4653000.0,,,,,,,,,,,17680000.0,398000.0,,,,-33000.0,,,,-61000.0,-28000.0,121000.0,-79000.0,,,,,148000.0,,87205000.0,140000.0,1e-05,10000000.0,0.0,0.0,,6213000.0,,,,,,,,1316000.0,80552000.0,,,,-23998000.0,,1432000.0,,,24245000.0,,,225000.0,,-307809000.0,,,96300000.0,,,225000.0,2660000.0,,,,,,,,,,,0.902,0.898,,0.0097,0.0011,2730013.0,12.22,,1158840.0,17.29,66300000.0,5698164.0,14.27,66300000.0,5698164.0,14.27,8.46,14.08,23.41,37300000.0,259334000.0,,14647.0,94149.0,,,1316000.0,,,,,,,,,,,,,,,,,,,,,44224169.0,,,
2021-06-30,2021-08-04,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,7905000.0,,3780000.0,20096000.0,829000.0,,-59000.0,696157000.0,3936000.0,3936000.0,,,404232000.0,371818000.0,,,,,,,,192412000.0,,192637000.0,,185000000.0,,1e-05,90000000.0,47525560.0,47525560.0,,-30868000.0,,,,400000.0,2009000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,7077000.0,,11396000.0,-0.69,,0.21,,,,,,,,46400000.0,,,,,,6715000.0,,-30842000.0,,,,0.0,,2778000.0,,,,,,,,,,,,,,,,97000.0,,,,,,,,,,,46785000.0,404232000.0,42973000.0,,,,161868000.0,26122000.0,,,,,,,,-30842000.0,,,,33147000.0,-30882000.0,,,1567000.0,3691000.0,,4349000.0,,,,,,,,,,,20096000.0,511000.0,,,,-34000.0,,,,-26000.0,8000.0,121000.0,-57000.0,,,,,,,,,1e-05,10000000.0,0.0,0.0,,7683000.0,,,,,,,,,,,,,,,1718000.0,,,26432000.0,,,225000.0,,-338651000.0,,,,,,,,,,,,,,,,,,0.888,0.88,,0.0111,0.0085,2980187.0,12.39,,,,173100000.0,5961336.0,15.84,173100000.0,5961336.0,15.84,,,,96800000.0,357447000.0,,,,,123798000.0,1247000.0,,,,,,,,,,,,,,,,,,,,,44864637.0,,,
2021-09-30,2021-11-03,10-Q,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,706000.0,,4722000.0,33061000.0,1566000.0,,-204000.0,702319000.0,4775000.0,4775000.0,,,373175000.0,327687000.0,,,,,,,,120542000.0,,120767000.0,,116068000.0,,1e-05,90000000.0,47671654.0,47671654.0,,-33949000.0,,,,200000.0,2241000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100000.0,,0.5,3500.0,,,,2638000.0,,1121000.0,-0.7,,0.21,,,,,,,,51500000.0,,,,,,7256000.0,,-33804000.0,,,,0.0,,1871000.0,,,,,,,,,,,,,,,,122000.0,,7120000.0,,2660000.0,,,1160000.0,2744000.0,556000.0,855000.0,43515000.0,373175000.0,39156000.0,,,,193759000.0,38169000.0,,,,,,,,-33804000.0,,,,44212000.0,-33926000.0,,6265000.0,2027000.0,4238000.0,,5371000.0,,,,,,,,,,0.096,33061000.0,791000.0,,,,-140000.0,,,,-145000.0,-5000.0,121000.0,,,,,,,,,,1e-05,10000000.0,0.0,0.0,,8877000.0,,,,,,,,,,,,,,,1723000.0,,,36956000.0,,,225000.0,,-372455000.0,10286000.0,,,,,,,,,,,,,,,,,,,,,,3121045.0,12.89,,,,27600000.0,6083955.0,17.54,27600000.0,6083955.0,17.54,,,,18700000.0,329660000.0,,,,,6000.0,1381000.0,,,,,,,,,,,,,,,,,,,,,47987184.0,,,
2021-12-31,2022-02-28,10-K,"PROTAGONIST THERAPEUTICS,Â INC.",PTGX,CIK0001377121,USD,1600000.0,-1830000.0,7125000.0,37716000.0,734000.0,4258000.0,-299000.0,709682000.0,16395000.0,16395000.0,,9170067.0,347695000.0,340736000.0,,,,,,143000.0,,123665000.0,,123890000.0,6072000.0,115335000.0,,1e-05,90000000.0,47838330.0,47838330.0,,-125878000.0,,,,,1601000.0,,2800000.0,,,,,,,,,,,,,,,,1037000.0,,,,104945000.0,,,,75649000.0,,,1153000.0,21197000.0,,103908000.0,1037000.0,,300000.0,,0.5,3500.0,813000.0,813000.0,,1566000.0,,899000.0,-2.71,,0.21,-0.28,,,0.008,0.019,,-126000.0,46300000.0,,,,,,27196000.0,-125797000.0,-125551000.0,246000.0,,,0.0,,2792000.0,,-1833000.0,-1390000.0,-860000.0,-12876000.0,,1775000.0,19097000.0,,-121000.0,3227000.0,,,,,443000.0,1871000.0,6564000.0,,2660000.0,,,1160000.0,2744000.0,,706000.0,47674000.0,347695000.0,44016000.0,,,,203235000.0,,0.0,129923000.0,,-15860000.0,,-107865000.0,,-125551000.0,,,1.0,153202000.0,-125845000.0,1962000.0,5858000.0,2200000.0,3658000.0,2049000.0,4936000.0,,,,,,,,,,0.104,37716000.0,407000.0,,,,-182000.0,,,,-327000.0,-145000.0,,-149000.0,1515000.0,975000.0,,,,,286589000.0,1101000.0,1e-05,10000000.0,0.0,,,9478000.0,1746000.0,,,123829000.0,,,,6283000.0,271830000.0,,,,-125551000.0,6056000.0,1798000.0,,,126006000.0,,,225000.0,,-409362000.0,27357000.0,,,,1373000.0,,16395000.0,,,,,,,,,,,,,,,,3224575.0,13.13,10500000.0,1949940.0,21.94,102700000.0,5890540.0,17.66,102700000.0,5890540.0,17.66,11.34,17.84,29.96,68100000.0,300021000.0,,232719.0,474801.0,,123804000.0,6283000.0,,,91000.0,,,,,,,,,0.0,33159000.0,,0.0,,13274000.0,,,32000000.0,46322910.0,1500000.0,1962000.0,11300000.0
